Zymeworks Inc.ZYMENASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank73
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P73
Within normal range
vs 3Y Ago
-2.4x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM-84.27%+40.8%
2024-142.36%+10.4%
2023-158.79%-559.7%
202234.54%+104.5%
2021-772.45%-63.7%
2020-471.79%+5.9%
2019-501.34%-764.3%
2018-58.01%-393.6%
2017-11.75%+96.4%
2016-329.37%-